AstraZeneca Shares Rise 3% as CDSCO Approves Sale of Tremelimumab
AstraZeneca Pharmaceuticals India shares rose more than 3% in morning trade on June 2 after the CDSCO approved the sale and distribution of Tremelimumab (Imjudo)...
Download Unicorn Signals App
Powered By EquityPandit
